VIBERZI®

Hold Company

ABBVIE

Learn More

Dosage and Administration

TABLET;ORAL

Specification

75MG; 100MG

Indication

VIBERZI® is indicated for the treatment of adult irritable bowel syndrome with diarrhea (IBS-D).

Use

Instructions for Use

API

ELUXADOLINE

API Structure

We Supply

ELUXADOLINE

Note:

DMF is preparing

null

Note:

null

null

Note:

null

Drug Patent

Patent No	Expiration Date
10188632	2033/3/14
10213415	2025/3/14
11007179	2033/3/14
11090291	2033/3/14
11160792	2033/3/14
11229627	2033/3/14
11311516	2033/3/14
7741356	2029/5/27
7786158	2025/3/14
8344011	2025/3/14
8609709	2025/3/14
8691860	2028/7/7
8772325	2025/3/14
9115091	2028/7/7
9205076	2025/3/14
9364489	2028/7/7
9675587	2033/3/14
9700542	2025/3/14
9789125	2028/7/7

API Patent

Patent No	Expiration Date
10213415	2025/3/14
7741356	2029/5/27
7786158	2025/3/14
8344011	2025/3/14
8609709	2025/3/14
8772325	2025/3/14
9205076	2025/3/14
9700542	2025/3/14

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.